The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01AI141707-02
Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins
National Institutes of Health
Grant: 5UM1AI148576-02
Vaccine and Treatment Evaluation Units
National Institutes of Health
Grant: 1S10OD028685-01
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research
National Institutes of Health
Grant: 5F30AI149928-02
Complete mapping of the functional and antigenic effects of mutations to Lassa virus glycoprotein
National Institutes of Health
Grant: 3UM1AI148684-03S1
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
National Institutes of Health
Grant: 3UM1AI148373-02S1
Kaiser Washington Vaccine and Treatment Evaluation Unit
National Institutes of Health
Grant: 5R01AI127893-05
High-throughput experiments to guide influenza vaccine strain selection
National Institutes of Health
Grant: 3P51OD011132-64S2
Renovation to expand and enhance NHP housing for HIV/AIDS research at the Emory NPRC
National Institutes of Health
Grant: 1U01AI149644-01
Respiratory Virus Vaccine and Adjuvant Exploration
National Institutes of Health
Grant: 1T32AI083203-01
Viral Pathogenesis Training Program
Fields of Study
Keywords
Sustainable Development Goals